Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

HealthDay News — Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published online March 5 in JAMA Surgery ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

But the newest study that has gone viral is an even more impressive outcome. Headlines are claiming that researchers have ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

which is the most effective and durable treatment to lose weight and reduce the risk of death from heart disease, stroke, cancer and diabetes. Previous studies have found that taking semaglutide after ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...